IMPELLA CP 0048-0004

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2016-05-05 for IMPELLA CP 0048-0004 manufactured by Abiomed Europe, Gmbh (germany).

Event Text Entries

[44553018] The device was returned to the manufacturer for evaluation. The impella cp was evaluated and the aic logs were analyzed. A review of the data logs showed that the pump was inserted at approximately 14:16 on (b)(6) 2016. The pump was then started one minute later. At 14:45 there was an "impella position unknown" alarm. This may have been the result of the pump having been pulled out of the ventricle at this point. The evaluation of the pump revealed that there was a kink at the 56cm mark, and the wound closure sheath had been damaged. The tip of the repositioning sheath did not appear to be damaged. The catheter was cut by the evaluating engineers so that the repositioning sheath could be examined. The wound closure sheath was found to be cracked and torn in the area where it transitions to the sheath. A fluoroscopy image was also submitted for analysis. The image from the case showed the position of the repositioning sheath and was interpreted as showing the repositioning sheath positioned alongside of the artery. It appears that this was responsible for pulling the catheter back out of the heart and into the patient's abdomen. This could have contributed to the kink and the damage sheath that was observed during the failure analysis. Failures of the wound closure sheath in the past have been attributed to the manufacturing process of flash removal which could result in small cracks and tears in the wound closure sheath and can contribute to failure of the device when under stress. In conclusion, the root cause of the damage to the repositioning sheath was that the sheath and catheter were pushed up alongside the artery during placement. This event may have been avoided with the careful use of fluoro guidance. The impella cp instructions for use warns the user of the following: never advance the guidewire or sheath when resistance is met. Determine the cause of resistance using fluoroscopy and take remedial action. Fluoroscopy is required to guide placement of the impella? Catheter. The small placement guidewire must be reliably observed at all times. The manufacturing process of flash removal was corrected with a product change. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[44553019] The complainant reported that a (b)(6) year old "heavy set" male patient in cardiogenic shock due to an occluded left main (lm) was transferred to this facility for the placement of an impella cp. The physician reported that the patient was in cardiogenic shock due to thrombus in the left main. The patient's lvedp was elevated at 40 and he was on levophed of 15ug/minute. The physician completed revascularization by removing a clot in the lm and no stents were needed. The 14 french peel away sheath was inserted effortlessly, but the physician was observed having difficulty with the repositioning sheath, and appeared to be "fussing over it. " the physician performed the placement of the repositioning sheath without the aid of fluoro coverage. Within 3 minutes of placement the impella catheter migrated out of the ventricle. Adjustments were made and catheter fluoro images were then taken of the groin. The images indicated that the catheter was in the patient's abdomen. Ten to fifteen minutes later, the patient became hemodynamically unstable and started bleeding. Anesthesia, vascular surgery and another interventionalist were called to assist. They did see under fluoro what appeared to be two puncture sites that were sites of blood loss. One was seen to be above the access site and was bleeding profusely, while the one below was not bleeding out to that extent. The fluoro images indicated that the cannula tracked along the side of the artery and had never entered the artery. A balloon catheter was inserted via the left femoral artery and occluded the right artery proximally. Unfortunately, the patient expired before the vascular surgeon could intervene. The staff reported that the cause of the patient outcome cause was reported as "stemi"; furthermore, the team stated that the patient would have expired without the impella device.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1220648-2016-00009
MDR Report Key5635857
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2016-05-05
Date of Report2016-04-05
Date of Event2016-04-05
Date Facility Aware2016-04-05
Report Date2016-04-05
Date Reported to Mfgr2016-04-05
Date Mfgr Received2016-04-05
Device Manufacturer Date2015-12-03
Date Added to Maude2016-05-05
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. WILLIAM BOLT
Manufacturer StreetABIOMED, INC. 22 CHERRY HILL DRIVE
Manufacturer CityDANVERS MA 01923
Manufacturer CountryUS
Manufacturer Postal01923
Manufacturer Phone9786461451
Manufacturer G1ABIOMED EUROPE, GMBH (GERMANY)
Manufacturer StreetNEUEHOFER WEG 3
Manufacturer CityAACHEN, GERMANY 13059, GM
Manufacturer CountryGM
Manufacturer Postal Code13059, GM
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameIMPELLA CP
Generic NameIMPELLA CP
Product CodePBL
Date Received2016-05-05
Returned To Mfg2016-04-11
Model NumberIMPELLA CP
Catalog Number0048-0004
Lot Number1215341
Device Expiration Date2017-03-03
OperatorPHYSICIAN
Device AvailabilityR
Device Age4 MO
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABIOMED EUROPE, GMBH (GERMANY)
Manufacturer AddressNEUEHOFER WEG 3 AACHEN, GERMANY 13059, GM GM 13059, GM


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2016-05-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.